Breaking News Instant updates and real-time market news.

LOW

Lowe's

, SWHC

Changed to AOBC

$26.16

-0.08 (-0.30%)

09:40
10/06/16
10/06
09:40
10/06/16
09:40

Unusually active option classes on open October 6th

Unusual total active option classes on open include: Lowes (LOW), WisdomTree India Earnings (EPI), Smith and Wesson (SWHC), Yum! Brands (YUM), Salesforce.com (CRM), MetLife (MET), Energy Transfer Equity (ETE), Walmart (WMT), Abercrombie & Fitch (ANF), and Coca Cola (KO).

LOW

Lowe's

SWHC

Changed to AOBC

$26.16

-0.08 (-0.30%)

YUM

Yum! Brands

CRM

Salesforce

MET

MetLife

ETE

Energy Transfer Equity

WMT

Wal-Mart

ANF

Abercrombie & Fitch

KO

Coca-Cola

  • 06

    Oct

  • 11

    Oct

  • 23

    Oct

  • 26

    Oct

  • 03

    Nov

  • 17

    Nov

LOW Lowe's

10/06/16
10/06/16
DOWNGRADE

Neutral
Lowe's downgraded on end market demand, execution at Cleveland Research
As previously reported, Cleveland Research downgraded Lowe's to Neutral from Buy. Analyst led by Eric Bosshard's work suggest a moderation in demand in the building product categories generally and in homecenter categories over the last 4-5 months. He sees Lowe's struggling to sustain the upside execution needed to post growth ahead of Street expectations and has concerns with diversification efforts and would prefer the company focus on improving execution in its core US business.
09/19/16
BARD
09/19/16
NO CHANGE
Target $88
BARD
Outperform
Lowe's risk/reward remains attractive, says Baird
Baird analyst Peter Benedict said the recent pullback in Lowe's shares is an attractive buying opportunity. The analyst cited macro drivers, consistency around key operating initiatives, and a durable financial model capable of delivering high-teens earnings growth over the next few years. Benedict reiterated his Outperform rating and $88 price target on Lowe's shares.
10/06/16
CLVD
10/06/16
DOWNGRADE
CLVD
Neutral
Lowe's downgraded to Neutral from Buy at Cleveland Research
08/26/16
OPCO
08/26/16
NO CHANGE
Target $94
OPCO
Outperform
Lowe's should be bought on weakness, says Oppenheimer
Oppenheimer analyst Brian Nagel believes that the recent sales weakness at Lowe's reflects primarily unfavorable weather. The analyst sees the company as a "very well-positioned" chain in a sector benefiting from some of the strongest demand growth in retail and recommends using any weakness as a buying opportunity. Nagel reiterates an Outperform rating and $94 price target on the shares.
SWHC Changed to AOBC
$26.16

-0.08 (-0.30%)

09/26/16
COWN
09/26/16
NO CHANGE
Target $34
COWN
Outperform
Smith & Wesson potential selection by Army not included in guidance, says Cowen
Cowen analyst Cai von Rumohr said it was surprising that Smith & Wesson was not selected by the Army to compete in the testing phase of the Modular Handgun System, or MHS, project, but also noted that MHS was not included in the company's guidance. The analyst, who thinks S&W shares still look cheap, keeps an Outperform rating on the gunmaker's stock, which is down over 4% to $26.40 in pre-market trading.
10/06/16
WDLK
10/06/16
DOWNGRADE
Target $29
WDLK
Hold
Smith & Wesson downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Rommel Dionisio downgraded Smith & Wesson to Hold and lowered his price target for the shares to $29 from $36 citing decelerating industry demand.
09/02/16
CHLM
09/02/16
DOWNGRADE
Target $33
CHLM
Hold
Smith & Wesson downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Steven Dyer downgraded Smith & Wesson to Hold from Buy, as he thinks the current environment is "as good as it gets" for firearms demand. Based on past cycles, Dyer contends that November's election and activity right after that will likely mark the top of the current firearms cycle and the stock will react as comps become more difficult. Dyer lowered his price target on Smith & Wesson shares to $33 from $35.
09/02/16
09/02/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Carnival (CCL) downgraded to Underweight from Equal Weight at Morgan Stanley by analyst Jamie Rollo after the firm's checks indicated cruise demand weakened and prices were soft in August. The analyst lowered Carnival's price target to $48 from $54. 2. lululemon (LULU) downgraded to Equal Weight from Overweight by Morgan Stanley analyst Kimberly Greenberger following the company's earnings report. She noted that the company's comps are decelerating and that traffic remains a headwind. Given the slowdown seen in Q2, Greenberger lowered her comp assumptions and cut her price target on lululemon shares to $70 from $74. 3. Morgan Stanley analyst Meta Marshall downgraded Ciena (CIEN) to Equal Weight from Overweight, saying that while the company can likely outgrow the market over the next couple of years, its industry remains intensely competitive and growth is slowing in the long haul market, leaving little room for multiple expansion. Marshall maintains a $23 price target on Ciena shares. 4. Smith & Wesson (SWHC) downgraded to Hold from Buy at Craig-Hallum by analyst Steven Dyer, as he thinks the current environment is "as good as it gets" for firearms demand. Based on past cycles, Dyer contends that November's election and activity right after that will likely mark the top of the current firearms cycle and the stock will react as comps become more difficult. 5. STMicroelectronics (STM) downgraded to Underperform from Neutral at BofA/Merrill, with the firm saying structural pressures will drive declining revenue from Q3 of 2017 and beyond. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
YUM Yum! Brands

10/06/16
OPCO
10/06/16
NO CHANGE
Target $97
OPCO
Outperform
Oppenheimer would be aggressive buyer of Yum! Brands below $90
After Yum! Brands reported an in-line earnings quarter, Oppenheimer analyst Brian Bittner remains attracted to the shares ahead of several catalysts. The analyst would be an aggressive buyer of Yum! Brands below $90 per share. He reiterates an Outperform rating and $97 price target on the stock.
09/23/16
09/23/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Underperform from Sector Perform by RBC analyst Mark Mahaney, who cut his price target to $14 from $17. The research firm's survey of more than 1,100 advertising professionals and their attitudes towards Facebook (FB), Google (GOOG), Twitter and other high-profile names showed that, despite marketing budgets continuing to shift online, interest in the microblog platform appears to be declining. Of note, Twitter shares have surged this morning after CNBC's David Faber reported that Twitter is moving closer to selling itself and has received expressions of interest in a possible sale, although no deal is imminent. 2. Yum! Brands (YUM) downgraded to Outperform from Top Pick by RBC Capital analyst David Palmer based on valuation. His price target on Yum shares remains $97. 3. Becton Dickinson (BDX) downgraded to Sell from Neutral by Citi analyst Amit Hazan, who thinks a cyclical U.S. slowdown will push the company's organic growth below expectations. The analyst, who also sees a diminishing impact on Becton's growth from emerging markets, cut his price target for the shares to $165 from $167. 4. NextEra Energy (NEE) downgraded to Hold from Buy by Deutsche Bank analyst Jonathan Arnold, as he sees limited near-term upside with the shares up 23% year-to-date. "Extraordinarily frosty commentary" from two of three PUCT commissioners yesterday regarding NextEra's Oncor deal indicates an uphill battle in getting it approved, Arnold tells investors. 5. AVANGRID (AGR) downgraded to Underweight from Neutral by JPMorgan analyst Christopher Turnure, who thinks both the company's growth guidance and consensus expectations "appear ambitious." He lowered his price target for the shares to $41 and $44 and notes he does not have confidence in AVANGRID's near-term growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/29/16
OPCO
09/29/16
NO CHANGE
Target $97
OPCO
Outperform
Yum! Brands remains a favorite at Oppenheimer
Oppenheimer analyst Brian Bittner says Yum! Brands remains one of his "favorite Outperforms," despite its 23% year-to-date gain. The analyst raised his price target on the stock to $97 from $96, citing his updated sum-of-parts heading into the October 31 separation of the company's China business. Nonetheless, Bittner notes that this does not incorporate additional potential upside from an attractive G&A opportunity, potential for larger than expected capital returns post-separation at both entities, and continued earnings power restoration at Yum China. He reiterates an Outperform rating on the shares.
09/29/16
BERN
09/29/16
NO CHANGE
BERN
New Yum! poised to benefit from cost cutting, unit growth, says Bernstein
Bernstein analyst Sara Senatore says that New Yum! - the global franchisor of KFC, Pizza Hut, and Taco Bell which will trade separately from the current company's China assets following an upcoming spin off - should benefit from cost cutting and steady unit growth. New Yum! will be able to cut up to $140M+.of costs, and "steady unit growth" should "provide underlying support" for its revenue, she stated. The analyst keeps a $98 price target and Outperform rating on current, combined Yum!.
CRM Salesforce

10/06/16
BMOC
10/06/16
NO CHANGE
BMOC
Twitter acquisition would hurt Salesforce, says BMO Capital
BMO Capital analyst Keith Bachman says that an acquisition of Twitter (TWTR) by Salesforce (CRM) would " offer little strategic fit, would slow revenue growth and would be dilutive to (free cash flow) margins." Bachman thinks that the deal would cause Salesforce's stock to drop significantly,. and he says that the company's stock would be worth $65 if it pulls the trigger on Twitter. The analyst says that Salesforce's current valuation is attractive if it does not buy Twitter. He keeps an $86 price target and Outperform rating on Salesforce.
10/06/16
BARD
10/06/16
NO CHANGE
Target $90
BARD
Outperform
Salesforce shares should be bought, says Baird
Baird analyst Steven Ashley noted that Salesforce (CRM) CEO Mark Benioff said his company has all the customer data it needs, which he reads as meaning it would not need to make an acquisition of Twitter (TWTR) purely for data. The analyst also said the company's board is acutely aware of their responsibility to shareholders when it comes to Salesforce's stock and the potential negative impact on shares that a Twitter deal could pose. Ashley reiterated his Outperform rating and $90 price target on Salesforce shares.
10/06/16
COWN
10/06/16
NO CHANGE
Target $100
COWN
Outperform
Salesforce shares should rebound with no Twitter deal, says Cowen
Cowen analyst J.Derrick Wood expects shares of Salesforce (CRM) to rebound if the company does not buy Twitter (TWTR), which he believes will not happen. The analyst believes investors will return to fundamentals and the analyst believes upside momentum in Salesforce's core business will return in Q3. Wood reiterated his Outperform rating and $100 price target on Salesforce shares.
10/06/16
ROTH
10/06/16
NO CHANGE
Target $103
ROTH
Buy
Salesforce should be bought on pullback, says Roth Capital
Roth Capital analyst Richard Baldry says Salesforce's (CRM) shares are down roughly 20% from their recent highs, pressured by rumors of a potential bid for Twitter (TWTR) and a recent revenue guidance increase for the second half of 2017 that was back-end loaded enough to leave his Q3 forecast lowered. However, the analyst believes the pullback offers investors an attractive entry point and advocates buying on weakness. Baldry reiterates a Buy rating and $103 price target on Salesforce's shares given the company's strong fundamentals and sector dominance.
MET MetLife

09/22/16
WELS
09/22/16
INITIATION
WELS
Outperform
MetLife coverage resumed with an Outperform at Wells Fargo
07/13/16
DBAB
07/13/16
DOWNGRADE
Target $44
DBAB
Hold
MetLife downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Yaron Kinar downgraded MetLife to Hold saying balance sheet risk is enhanced ahead of the company's separation and in light of low yields. The analyst does not expect the separation to be executed before year-end, and therefore does expect buybacks before 2017. He sees a lack of near-term catalysts for MetLife and lowered his price target for the shares to $44 from $47.
07/13/16
07/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Underperform from Market Perform at Wells Fargo with analyst Peter Stabler saying consensus expectations "embed too much optimism" for 2017 and 2018. 2. Starbucks (SBUX) downgraded to Mixed from Positive at OTR Global with the firm citing manager checks that indicate weaker-than-expected food and Frappuccino sales, impact from poor weather, and cannibalization. 3. SQM (SQM) downgraded to Sell from Neutral at Citi analyst Juan Tavarez saying the risk/reward is unfavorable with the stock up 42% year-to-date. 4. Robert Half (RHI) downgraded to Neutral from Buy at BofA/Merrill with the firm citing expectations of weaker fundamentals, FX headwinds, and increased concerns around the timing of the cycle. 5. MetLife (MET) downgraded to Hold from Buy at Deutsche Bank with analyst Yaron Kinar saying balance sheet risk is enhanced ahead of the company's separation and in light of low yields. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/23/16
WELS
09/23/16
INITIATION
WELS
Outperform
MetLife coverage resumed at Wells Fargo
As noted earlier, Wells Fargo resumed coverage of MetLife with an Outperform rating. The firm says that , in the wake of the company's decision to separate its retail business, it "should be less impacted by equity market movement and interest rates." As a result, the firm thinks that the stock's multiple should rise, while the company should require less capital, enabling it to buy back its shares. Wells set a $51-$53 price target on the stock.
ETE Energy Transfer Equity

09/26/16
BARD
09/26/16
UPGRADE
BARD
Outperform
Energy Transfer Equity upgraded to Outperform from Neutral at Baird
09/26/16
BARD
09/26/16
UPGRADE
BARD
Outperform
Energy Transfer Equity, Energy Transfer Partners upgraded to Outperform at Baird
As previously reported, Baird analyst Ethan Bellamy upgraded Energy Transfer Equity (ETE) and Energy Transfer Partners (ETP) to Outperform from Neutral as he believes the leverage situation is contained in the near-term and that its distributions are likely to remain stable through 2018. Bellamy raised his price target on Energy Transfer Equity to $20 from $7 and took up his target on Energy Transfer Partners to $45 from $25.
09/29/16
SPHN
09/29/16
INITIATION
Target $20
SPHN
Equal Weight
Energy Transfer Equity initiated with an Equal Weight at Stephens
Stephens analyst Matt Schmid started Energy Transfer Equity with an Equal Weight rating and $20 price target.
09/29/16
MZHO
09/29/16
INITIATION
Target $20
MZHO
Buy
Energy Transfer Equity initiated with a Buy at Mizuho
Mizuho initiated Energy Transfer Equity with a Buy and a $20 price target.
WMT Wal-Mart

09/30/16
09/30/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN) initiated with a Buy at Guggenheim. 2. Wal-Mart (WMT) initiated with an Overweight at KeyBanc and a Buy at Guggenheim. 3. Harley-Davidson (HOG) initiated with a Hold at Jefferies. 4. Coach (COH) was initiated with a Buy at Guggenheim while the firm initiated Michael Kors (KORS) with a Neutral. 5. First Solar (FSLR) initiated with a Buy at Williams Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
GUGG
09/30/16
INITIATION
Target $82
GUGG
Buy
Wal-Mart initiated with a Buy at Guggenheim
Guggenheim analyst Robert Drbul initiated Wal-Mart with a Buy and a $82 price target saying it is successfully adapting to the rapidly changing consumer environment and remains laser focused on improving its critical U.S. supercenter business.
09/29/16
KEYB
09/29/16
INITIATION
Target $90
KEYB
Overweight
Wal-Mart initiated with an Overweight, momentum building, says KeyBanc
As previously reported, KeyBanc initiated Wal-Mart with an Overweight and a $90 price target. Analyst Edward Yruma believes Wal-Mart's investments in e-commerce and technology will drive sustainable market share gains and return the company to both consistent revenue and EBITDA growth in 2017.
09/29/16
KEYB
09/29/16
INITIATION
Target $90
KEYB
Overweight
Wal-Mart initiated with an Overweight at KeyBanc
KeyBanc initiated Wal-Mart with an Overweight and a a $90 price target.
ANF Abercrombie & Fitch

09/06/16
JEFF
09/06/16
NO CHANGE
Target $45
JEFF
Buy
Urban Outfitters added to Franchise Picks list at Jefferies
Jefferies analyst Randal Konik added Urban Outfitters to his firm's Franchise Picks list and upped his price target for the shares to $45 from $40. The company is positioned to benefit from an improving fashion cycle and changes in footwear trends, Konik tells investors in a research note. He keeps a Buy rating on Urban. The analyst removed Abercrombie & Fitch (ANF) from the Franchise Picks list.
10/05/16
KEYB
10/05/16
DOWNGRADE
KEYB
Sector Weight
Abercrombie & Fitch downgraded to Sector Weight from Overweight at KeyBanc
10/05/16
KEYB
10/05/16
DOWNGRADE
KEYB
Sector Weight
Abercrombie & Fitch downgraded to Sector Weight at KeyBanc
As previously reported, KeyBanc analyst Jessica Schmidt downgraded Abercrombie & Fitch to Sector Weight from Overweight after the firm's proprietary promotional database and channel checks suggest that promotions at its Abercrombie and Hollister brands are higher than at this time last year. The elevated promotions add to other headwinds, including the fact that the teen space is "overstored" and faces soft consumer demand and weak tourism, said Schmidt.
09/14/16
SBSH
09/14/16
UPGRADE
Target $44
SBSH
Buy
Macy's upgraded to Buy from Neutral at Citi
Citi analyst Paul Lejuez upgraded Macy's (M) to Buy saying an attractive free cash flow and dividend yield makes the risk/reward attractive at current levels. While the long term structural challenges to department stores are unlikely to go away, Macy's is "doing the right things for the business," Lejuez tells investors in a research note. He calls the retailer "one of the stronger horses in the race" and sees upcoming quarterly results as potential catalysts. Lejuez keeps a $44 price target for Macy's shares. The analyst points out that Macy's 4.4% dividend yielding 4.4% trails only Kohl's (KSS) and Abercrombie & Fitch (ANF) among the retailers he covers. Macy's closed yesterday down 59c to $34.68.
KO Coca-Cola

09/29/16
STFL
09/29/16
DOWNGRADE
STFL
Hold
Coca-Cola downgraded to Hold from Buy at Stifel
09/29/16
STFL
09/29/16
DOWNGRADE
STFL
Hold
Coca-Cola downgraded following Pepsi results at Stifel
As noted earlier, Stifel analyst Mark Swartzberg downgraded Coca-Cola (KO) to Hold from Buy. The analyst downgraded the stock after Pepsi (PEP) reported better than expected Q3 results. The analyst says that Coca-Cola's and Pepsi's organic EPS growth appears to be similar, but he believes that Pepsi is less vulnerable to foreign exchange fluctuations. Additionally, he believes that Coca Cola European Bottlers (CCE) is a better investment than Coca-Cola because of the large amount of revenue synergies which that Coca Cola European Bottlers has identified.
09/29/16
09/29/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Coca-Cola (KO) downgraded to Hold from Buy at Stifel with analyst Mark Swartzberg saying that Coca-Cola's and Pepsi's organic EPS growth appears to be similar, but he believes that Pepsi is less vulnerable to foreign exchange fluctuations. 2. Fitbit (FIT) downgraded to Underweight from Sector Weight at Pacific Crest analyst Brad Erickson citing his channel checks which indicated that Charge 2, the company's flagship holiday product, is off to a slow start. 3. Discovery (DISCA) downgraded to Market Perform from Outperform at Barrington with analyst James Goss saying that Brexit and sports costs are dragging on its international results and foreign exchange tailwinds are moderating in many geographies. 4. Sonus (SONS) downgraded to Underperform from Market Perform at Cowen with analyst Paul Silverstein saying the firm's industry checks uncovered operational challenges and ongoing employee and executive churn. 5. Alcobra (ADHD) downgraded to Hold from Buy at Cantor and to Perform from Outperform at Oppenheimer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/29/16
HSBC
09/29/16
NO CHANGE
HSBC
Buy
AB InBev's goal may be to acquire Coca-Cola, says HSBC
HSBC analyst Anthony Bucalo says SABMiller's (SBMRY) merger with AB InBev (BUD), which its shareholders just approved, will impact "nearly every major company across global beverages," especially Heinenken (HINKY). The combined company "represents a strong vehicle for another transaction" if InBev management chooses to do so, Bucalo tells investors in a research note dated yesterday. The analyst believes AB InBev's ultimate goal is the possible acquisition of The Coca-Cola Company (KO). The entire Coca-Cola bottling system, especially for Mexican giant FEMSA (FMX), is impacted by SABMiller joining with AB InBev, Bucalo contends.

TODAY'S FREE FLY STORIES

AGU

Agrium

$99.37

-1.19 (-1.18%)

, AAL

American Airlines

$46.28

0.18 (0.39%)

16:10
02/25/17
02/25
16:10
02/25/17
16:10
Conference/Events
BMO Capital to hold a conference »

26th Global Metals &…

AGU

Agrium

$99.37

-1.19 (-1.18%)

AAL

American Airlines

$46.28

0.18 (0.39%)

ABX

Barrick Gold

$19.54

-0.12 (-0.61%)

AEM

Agnico Eagle

$45.32

-0.06 (-0.13%)

ANTO

Use ANFGY

BLT

Blount

CCO

Clear Channel Outdoor

$4.65

0.1797 (4.02%)

FCX

Freeport McMoRan

$13.25

-0.23 (-1.71%)

FNV

Franco-Nevada

$65.89

-0.85 (-1.27%)

GEM

Pepsi-Gemex ADR

$29.39

-0.3 (-1.01%)

GG

Goldcorp

$16.57

-0.25 (-1.49%)

HBM

Hudbay Minerals

$8.00

0.25 (3.23%)

IVN

trades under IVPAF

NUE

Nucor

$60.86

-0.03 (-0.05%)

PDL

Project Design Labs

POT

Potash

$17.87

-0.2 (-1.11%)

RIO

Rio Tinto

$41.69

-0.82 (-1.93%)

SLW

Silver Wheaton

$21.15

-0.36 (-1.67%)

STLD

Steel Dynamics

$35.59

0.07 (0.20%)

TECK

Teck Resources

$20.72

-0.09 (-0.43%)

NEM

Newmont Mining

$36.08

0.22 (0.61%)

MOS

Mosaic

$31.42

-0.41 (-1.29%)

AA

Alcoa

$34.48

0.16 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 22

    Mar

  • 23

    Mar

  • 02

    May

SO

Southern Company

$50.50

0.83 (1.67%)

15:07
02/25/17
02/25
15:07
02/25/17
15:07
Conference/Events
Southern Company participates in a conference call with Wolfe Research »

Wolfe Utilties Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 03

    Mar

DK

Delek US

$23.19

-0.21 (-0.90%)

15:04
02/25/17
02/25
15:04
02/25/17
15:04
Conference/Events
Delek US management participates in a dinner meeting with Wolfe Research »

Wolfe Gas & Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

ANTM

Anthem

$163.83

-0.09 (-0.05%)

15:00
02/25/17
02/25
15:00
02/25/17
15:00
Conference/Events
Anthem management to meet with Wolfe Research »

Wolfe Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MCO

Moody's

$113.29

0.06 (0.05%)

14:56
02/25/17
02/25
14:56
02/25/17
14:56
Conference/Events
Moody's analysts participate in a meeting with Wolfe Research »

Wolfe Utilities Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 05

    Mar

ONCS

OncoSec

$1.39

-0.03 (-2.11%)

, NKTR

Nektar

$13.45

0.25 (1.89%)

04:55
02/25/17
02/25
04:55
02/25/17
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2017 ASCO-SITC Clinical…

ONCS

OncoSec

$1.39

-0.03 (-2.11%)

NKTR

Nektar

$13.45

0.25 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MMM

3M

$187.41

0.22 (0.12%)

, BIOL

BIOLASE

$1.49

-0.01 (-0.67%)

04:55
02/25/17
02/25
04:55
02/25/17
04:55
Conference/Events
Chicago Dental Society to hold a meeting »

Chicago Dental Midwinter…

MMM

3M

$187.41

0.22 (0.12%)

BIOL

BIOLASE

$1.49

-0.01 (-0.67%)

COF

Capital One

$92.61

-0.8 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNECY

Renesas

$4.14

-0.17 (-3.94%)

, ISIL

Intersil

19:04
02/24/17
02/24
19:04
02/24/17
19:04
Hot Stocks
Renesas sees Intersil acquisition accretive to non-GAAP EPS, free cash flows »

Renesas Electronics…

RNECY

Renesas

$4.14

-0.17 (-3.94%)

ISIL

Intersil

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSIC

Henry Schein

$173.53

1.61 (0.94%)

18:45
02/24/17
02/24
18:45
02/24/17
18:45
Conference/Events
Henry Schein management to meet with Jefferies »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

TWX

Time Warner

$97.28

0.6225 (0.64%)

18:38
02/24/17
02/24
18:38
02/24/17
18:38
Periodicals
Turner, Univision to win U.S. Champions League rights, Bloomberg reports »

Turner, a subsidiary of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

TRUE

TrueCar

$14.28

0.18 (1.28%)

18:33
02/24/17
02/24
18:33
02/24/17
18:33
Hot Stocks
TrueCar's ALG sees February total new vehicle sales 1.325M units, down 1.4% »

ALG projects total new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

GE

General Electric

$30.19

0.17 (0.57%)

18:24
02/24/17
02/24
18:24
02/24/17
18:24
Hot Stocks
GE does not see after-tax charges from GE Capital exit plan to exceed $23B »

GE said in a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CE

Celanese

$88.79

-0.88 (-0.98%)

18:02
02/24/17
02/24
18:02
02/24/17
18:02
Hot Stocks
Celanese announces vinyl acetate-based emulsions price increases in Asia »

Celanese announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

ELNK

EarthLink

$5.63

-0.22 (-3.76%)

, WIN

Windstream

$7.27

-0.02 (-0.27%)

17:56
02/24/17
02/24
17:56
02/24/17
17:56
Hot Stocks
EarthLink, Windstream holders approve merger »

EarthLink (ELNK)…

ELNK

EarthLink

$5.63

-0.22 (-3.76%)

WIN

Windstream

$7.27

-0.02 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 01

    Mar

  • 06

    Mar

PFE

Pfizer

$34.26

0.2 (0.59%)

17:43
02/24/17
02/24
17:43
02/24/17
17:43
Periodicals
Pfizer subpoenaed in investigation of charity connections, Bloomberg says »

Pfizer has received two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 09

    Mar

  • 17

    Mar

  • 23

    Mar

  • 01

    Apr

C

Citi

$59.56

-1.06 (-1.75%)

17:32
02/24/17
02/24
17:32
02/24/17
17:32
Hot Stocks
U.S. regulators investigating Citi over foreign hiring practices »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

FDX

FedEx

$193.11

1.93 (1.01%)

17:25
02/24/17
02/24
17:25
02/24/17
17:25
Hot Stocks
FedEx, USPS amend transportation agreement »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

URRE

Uranium Resources

$1.94

-0.09 (-4.43%)

17:21
02/24/17
02/24
17:21
02/24/17
17:21
Syndicate
Breaking Syndicate news story on Uranium Resources »

Uranium Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$153.48

0.19 (0.12%)

17:13
02/24/17
02/24
17:13
02/24/17
17:13
Hot Stocks
Raytheon awarded $1B government contract »

Raytheon Co., Woburn,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COTV

Cotiviti Holdings

$38.74

-0.06 (-0.15%)

17:06
02/24/17
02/24
17:06
02/24/17
17:06
Syndicate
Breaking Syndicate news story on Cotiviti Holdings »

Cotiviti Holdings files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

ENH

Endurance Specialty

$92.90

0.02 (0.02%)

17:05
02/24/17
02/24
17:05
02/24/17
17:05
Earnings
Endurance reports Q4 EPS 30c, may not compare to consensus $1.26 »

Reports Q4 gross premiums…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORPN

Bio Blast Pharma

$1.13

-0.0098 (-0.86%)

17:04
02/24/17
02/24
17:04
02/24/17
17:04
Syndicate
Breaking Syndicate news story on Bio Blast Pharma »

Bio Blast Pharma files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$15.40

0.3 (1.99%)

, PFE

Pfizer

$34.26

0.2 (0.59%)

16:44
02/24/17
02/24
16:44
02/24/17
16:44
General news
On The Fly: Stocks end week higher as rally continues »

Stocks ended the week…

MNTA

Momenta

$15.40

0.3 (1.99%)

PFE

Pfizer

$34.26

0.2 (0.59%)

STLD

Steel Dynamics

$35.59

0.07 (0.20%)

AKS

AK Steel

$8.02

-0.1 (-1.23%)

X

U.S. Steel

$37.01

-0.3 (-0.80%)

FLR

Fluor

$55.09

-0.26 (-0.47%)

GVA

Granite Construction

$53.91

0.78 (1.47%)

VMC

Vulcan Materials

$117.82

1.47 (1.26%)

PWR

Quanta Services

$37.76

0.62 (1.67%)

ACM

AECOM

$35.77

-0.58 (-1.60%)

JEC

Jacobs Engineering

$56.03

-0.07 (-0.12%)

KBR

KBR

$15.60

-0.55 (-3.41%)

CBI

CB&I

$33.87

-0.02 (-0.06%)

MTZ

MasTec

$40.10

3.05 (8.23%)

KHC

Kraft Heinz

$93.08

0.14 (0.15%)

UN

Unilever; also tag UL

$46.91

0.33 (0.71%)

UL

Unilever; also tag UN

$47.12

0.22 (0.47%)

QSR

Restaurant Brands

$55.47

-0.08 (-0.14%)

PLKI

Popeyes

TROX

Tronox

$17.40

-0.67 (-3.71%)

WMT

Wal-Mart

$72.39

1.08 (1.51%)

HD

Home Depot

$145.95

1.24 (0.86%)

CYH

Community Health

$9.22

0.32 (3.60%)

TOL

Toll Brothers

$33.74

-0.22 (-0.65%)

GRMN

Garmin

$53.03

0.72 (1.38%)

CHS

Chico's

$14.75

0.3 (2.08%)

HPQ

HP Inc.

$17.65

0.05 (0.28%)

CRI

Carter's

$90.04

2.98 (3.42%)

SQ

Square

$17.43

0.28 (1.63%)

JWN

Nordstrom

$46.46

2.52 (5.74%)

FL

Foot Locker

$75.01

6.43 (9.38%)

AAOI

Applied Optoelectronics

$45.98

8.51 (22.71%)

RH

Restoration Hardware

$31.34

6.15 (24.41%)

M

Macy's

$33.17

0.73 (2.25%)

PZZA

Papa John's

$78.70

-0.07 (-0.09%)

FSLR

First Solar

$37.90

0.71 (1.91%)

TXRH

Texas Roadhouse

$42.22

0.13 (0.31%)

TSLA

Tesla

$257.00

1.01 (0.39%)

LB

Labarge

$50.99

2.05 (4.19%)

W

Wayfair

$39.30

0.72 (1.87%)

HPE

HP Enterprise

$22.96

-1.7 (-6.89%)

JCP

J.C. Penney

$6.46

-0.4 (-5.83%)

ACIA

Acacia Communications

$54.04

-9.39 (-14.80%)

BGS

B&G Foods

$43.65

-3.25 (-6.93%)

SPLK

Splunk

$62.80

-2.1 (-3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 24

    Feb

  • 24

    Feb

  • 24

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 03

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 07

    Mar

  • 09

    Mar

  • 09

    Mar

  • 14

    Mar

  • 15

    Mar

  • 17

    Mar

  • 19

    Mar

  • 21

    Mar

  • 23

    Mar

  • 23

    Mar

  • 28

    Mar

  • 01

    Apr

  • 04

    Apr

  • 05

    Apr

  • 17

    Apr

NBEV

New Age Beverages

$3.90

-0.04 (-1.02%)

16:41
02/24/17
02/24
16:41
02/24/17
16:41
Hot Stocks
Breaking Hot Stocks news story on New Age Beverages »

Park West AM reports 6.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$1.71

-0.07 (-3.93%)

16:40
02/24/17
02/24
16:40
02/24/17
16:40
Hot Stocks
Breaking Hot Stocks news story on Cytori Therapeutics »

Azaya Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.